Navigation Links
MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
Date:1/31/2008

be described herein. Certain of these factors and other factors are described in detail in the Company's Annual Information Form and Annual Report on Form 20-F for and other filings with the Canadian securities regulatory authorities and the U.S. Securities & Exchange Commission.

Forward-looking statements are based on our current expectations and MIGENIX assumes no obligations to update such information to reflect later events or developments.

The Toronto Stock Exchange has not reviewed and does not accept

responsibility for the adequacy or accuracy of this release.

CONTACT: Art Ayres, MIGENIX Inc., Tel: (604) 221-9666 Ext. 233, aayres@migenix.com; Dian Griesel, Ph.D., Investor Relations Group, Tel: (212) 825-3210, Theproteam@aol.com


'/>"/>
SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
2. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
3. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
5. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
6. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
7. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
8. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
9. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
10. Phase 1 Studies Show Promise of QuatRxs Novel Compound, Sobetirome, for Lowering LDL Cholesterol Levels
11. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 ... ) has announced the addition of the ... Opportunities, 2018" report to their offering. ... Lack of data protection and old ... PIN codes have driven the growth of ...
(Date:6/19/2013)...   NineSigma , Inc., of Cleveland ... launch, NineSights.com is now the innovation engine ... worldwide community of innovators. From technology developers, ... NineSights stands out for its large community of innovators ... disciplines, all vetted by NineSigma. The community is free ...
(Date:6/19/2013)... 2013 BioConvergence team members Curtis ... at 2013’s BioLogistics Summit in San Francisco earlier ... Cold Chain IQ and IQPC, addressed the increasingly ... in part, attributed to current trends of globalization, ... these trends is an increase in movement, which ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Adding ... Pipette.com is now stocked with Simport’s Dropette® and ... aimed at the customer doing basic biology, chemistry and ... and serology). , For over 35 years, Simport has ... plastic labware - products like the Simport Dropette®. Simport’s ...
Breaking Biology Technology:Global Biometric Systems Market Forecast Report - Opportunities to 2018 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 3NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2
... p.m. (Pacific Time); ... http://www.adventrx.com , SAN DIEGO, March 13 ADVENTRX ... on in-licensing,developing and commercializing proprietary product candidates primarily for,the ... for the fourth quarter and year ended December 31, ...
... Brussels: THR), a biotechnology company focused on vascular,diseases, ... results for,the twelve month period ending 31 December ... to invest in its development,pipeline and has continued ... Highlights, - Successful placing of a total ...
... CITY, Mo., March 13 Proteon,Therapeutics, Inc. ( ... been issued by the European Patent Office. The ... of proteins known as elastases for,dilating arteries and ... related,United States patents in June and December of ...
Cached Biology Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 7ThromboGenics Announces 2007 Full Year Results 2ThromboGenics Announces 2007 Full Year Results 3ThromboGenics Announces 2007 Full Year Results 4Proteon Therapeutics Receives European Patent Covering New Method of Dilating Arteries and Veins 2
(Date:6/19/2013)... , June 19, 2013   ... clinical laboratory diagnostics technology for conducting on-demand, ... diabetes testing, as well as analysis of ... and platelet counts. The new system enables ... lab results for physicians and their patients, ...
(Date:6/19/2013)... patients who received injections of steroids contaminated with ... Compounding Center has found that some patients had ... a worsening of their symptoms and that magnetic ... among those individuals who received injections from highly ... an editorial by UC Davis Assistant Professor of ...
(Date:6/19/2013)... In the cover story for the journal Genetics ... the University of Massachusetts Amherst describe a new experimental ... the function of individual proteins in individual cell types ... allow deeper insights into protein function, Chase says, "because ... that single protein does when we isolate its function ...
Breaking Biology News(10 mins):Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4Evolution of an outbreak: Complications from contaminated steroid injections 2UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3
... 1, 2007A new Joslin-led study has shown that leptin, ... energy metabolism, plays a major role in islet cell ... new avenues for studying leptin and its role in ... for diabetes. This study appears in the October ...
... Engineers at Washington University in St. Louis are finding ... the heart during embryonic development. Larry A.Taber, ... Engineering, and Phillip Bayly, Ph.D., Hughes Professor of Mechanical ... in the folding of the brains surface, or cortex, ...
... , The New York Academy of Sciences, 7 World ... NY 10007 The Malaria Research Institute at the ... New York Academy of Sciences present Progress Against Malaria: ... the latest research developments in the fight to combat ...
Cached Biology News:Joslin researchers uncover potential role of leptin in diabetes 2Engineers study brain folding in higher mammals 2Engineers study brain folding in higher mammals 3Progress Against Malaria: Developments on the Horizon 2
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Request Info...
... Well Plate Sterile with ... range of 384-well plates ... screening and research. These ... and are suitable for ...
HLA-DRbeta (DA2)...
Biology Products: